Tue. Oct 4th, 2022
Glenmark Pharma gets USFDA nod for generic drug The company#39;#39;s US-based subsidiary has received final approval from the US Food and Drug Administration (USFDA) for the product which is a generic version of PF Prism CV#39;#39;s Rapamune tablets, Glenmark Pharmaceuticals said in a statement.